EXELTIS RETHINKING HEALTHCARE Trademark

Trademark Overview


On Wednesday, September 11, 2013, a trademark application was filed for EXELTIS RETHINKING HEALTHCARE with the United States Patent and Trademark Office. The USPTO has given the EXELTIS RETHINKING HEALTHCARE trademark a serial number of 79142730. The federal status of this trademark filing is PARTIAL SECTION 71 ACCEPTED as of Sunday, June 12, 2022. This trademark is owned by CHEMO IBERICA, S.A.. The EXELTIS RETHINKING HEALTHCARE trademark is filed in the Pharmaceutical Products, Medical Instrument Products, Advertising, Business and Retail Services, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for [ use in ] the treatment of ophthalmic diseases and disorders, dermatological diseases and disorders, digestive diseases and disorders, gynecological diseases and disorders; reagents for use in pregnancy tests; medical diagnostic reagents for use in ovulation tests; medical diagnostic reagents for use in testing for diabetes; contraceptives; pharmaceutical preparations for use in the treatment of hormonal diseases and disorders, blood disorders, cancer, cardiovascular diseases, [ vascular diseases, ] [ gastro-intestinal diseases, genitourinary diseases, ] * gastrointestinal disease, genitourinary disorders, * immunological diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders; pharmaceutical preparations for [ use in the ] treatment of [ neurological diseases and disorders, psychiatric diseases, diseases of the central nervous system, ] diseases of the musculoskeletal system, diseases of the respiratory system, [ diseases...

Sales promotion for third parties, business management assistance; [ consulting ] * consultancy * on business management and marketing studies; presentation of goods on [ any kind of ] * all * communication media for retail sale; commercial administration of licenses for the goods and services of others; organization of exhibitions, [ trade fairs or congresses for business ] * trade fairs and conventions for commercial * or advertising purposes, all relating to pharmaceutical, veterinary and biotechnological companies and for pharmaceutical, veterinary and biotechnological products * ; but none of the aforesaid goods relating to neuroscience, including dementia, Alzheimer's disease and Parkinson's disease or to goods in the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease *

[ Surgical apparatus and instruments, medical instruments for treating gynecological disorders, [ ophthalmological ] * ophthalmic * disorders, dermatological disorders, and respiratory and metabolic disorders; Medical test kits for diabetes monitoring for home use; orthopedic devices for diagnostic and therapeutic [ use ] * purposes * ; suture materials ]

[ Chemical, biological and pharmaceutical research services * ; [ all ] * none of * the aforesaid goods relating to the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease * ]
exeltis rethinking healthcare

General Information


Serial Number79142730
Word MarkEXELTIS RETHINKING HEALTHCARE
Filing DateWednesday, September 11, 2013
Status707 - PARTIAL SECTION 71 ACCEPTED
Status DateSunday, June 12, 2022
Registration Number4792387
Registration DateTuesday, August 18, 2015
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 2, 2015

Trademark Statements


Certificate of Correction for RegistrationIn the Statement, Page 1, lines 12 and 13, "gastro-intestinal diseases, genitourinary diseases" should be deleted, and, "gastrointestinal diseases, genitourinary disorders" should be inserted, and, In the Statement, Page 1, line 15, "use in the" should be deleted, and, In the Statement,Page 1, lines 16-18, "neurological diseases and disorders, psychiatric diseases, diseases of the central nervous system," should be deleted, and, In the Statement, Page 1, line 19, "diseases of the circulatory system," should be deleted, and, "circulatory diseases," should be inserted, and, In the Statement, Page 1, line 20, "headaches, migraines," should be deleted, and, In the Statement, Page 1, line 21, "in liver treatment" should be deleted, and, "treatment of the liver" should be inserted, and, "preparations" should be deleted, and, "products" should be inserted and In the Statement, Page 1, lines 25 and 28, "the" should be deleted, and, In the Statement, Page 1, line 27, " immunological diseases" should be deleted, and, "immunological disorders" should be inserted, and, In the Statement, Page 1, line 30, " headaches, migraines" should be deleted, and, In the Statement, Page 1, line 31, "liver treatment" should be deleted, and, "treatment of the liver" should be inserted, and, In the Statement, Page 1, line 34, after USE, "; none of the aforesaid products are preparations in connection with neuroscience, including dementia, Alzheimer's disease and Parkinson's disease" should be inserted, and, In the Statement, Page 2, line 2,"ophthalmological" should be deleted, and, "ophthalmic" should be inserted, and, In the Statement, Page 2, line 5, "use" should be deleted, and, "purposes" should be inserted, and, In the Statement, Page 2, line, 8, "consulting" should be deleted, and, "consultancy" should be inserted, and, In the Statement, Page 2, line 9, "any kind of" should be deleted, and, "all" should be inserted, and, In the Statement, Page 2, lines 11 and 12, "trade fairs or congresses for business" should be deleted, and, "trade fairs and conventions for commercial" should be inserted, and, In the Statement, Page 2, line 14, after PRODUCTS, "; but none of the aforesaid goods relating to neuroscience, including dementia, Alzheimer's disease and Parkinson's disease or to goods in the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease" should be inserted, and, In the Statement, Page 2, line 16, after SERVICES, "; all the aforesaid goods relating to the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease" should be inserted.
Description of the Colors ClaimedThe mark consists of the word "Exeltis" in dark blue, in rounded font and with the first letter capitalized, under which there is the phrase "Rethinking healthcare" in light blue, also in rounded font but smaller in size lower and with only the first letter of the first word capitalized. To the left of these words is a logo in dark blue and light blue consisting of seven leaves of diminishing size linked at their bases and opening in array with tips pointing outwards.
Goods and ServicesPharmaceutical preparations for [ use in ] the treatment of ophthalmic diseases and disorders, dermatological diseases and disorders, digestive diseases and disorders, gynecological diseases and disorders; reagents for use in pregnancy tests; medical diagnostic reagents for use in ovulation tests; medical diagnostic reagents for use in testing for diabetes; contraceptives; pharmaceutical preparations for use in the treatment of hormonal diseases and disorders, blood disorders, cancer, cardiovascular diseases, [ vascular diseases, ] [ gastro-intestinal diseases, genitourinary diseases, ] * gastrointestinal disease, genitourinary disorders, * immunological diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders; pharmaceutical preparations for [ use in the ] treatment of [ neurological diseases and disorders, psychiatric diseases, diseases of the central nervous system, ] diseases of the musculoskeletal system, diseases of the respiratory system, [ diseases of the circulatory system, ] * circulatory diseases, * viral diseases, glaucoma, dental and mouth diseases, [ headaches, migraines, ] obesity, cholesterol, [ in liver treatment ] * treatment of the liver * ; nutraceutical preparations for use as a dietary supplement; pharmaceutical [ preparations ] * products * for treating blood pressure and rheumatism; veterinary preparations for the treatment of digestive diseases and disorders, gynecological diseases and disorders, blood disorders, cancer, [ the ] treatment of cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, immunological [ diseases, ] * disorders, * infectious diseases, inflammatory diseases, metabolic diseases and disorders, [ the ] [ treatment of neurological diseases, ] the treatment of viral diseases, glaucoma, dental and oral diseases, [ headaches, migraines, ] obesity, [ liver treatment ] * treatment of the *, cholesterol; nutraceutical veterinary preparations for use as a dietary supplement; veterinary preparations for the treatment of blood pressure and for rheumatism; and dietetic foods, namely, crackers adapted for medical use * ; none of the aforesaid products are preparations in connection with neuroscience, including dementia, Alzheimer's disease and Parkinson's disease *
Certificate of Correction for RegistrationIn the statement, Page 2, line 7, "all" should be deleted, and "none of" should be inserted.
Certificate of Correction for RegistrationIn the statement, Page 1, line 5 "USE IN" should be deleted. In the statement, Page 1, line 12, "VASCULAR DISEASES," should be deleted. In the statement, Page 1, lines 27-28, "TREATMENT OF NEUROLOGICAL;" should be deleted.
Indication of Colors claimedThe color(s) dark blue and light blue is/are claimed as a feature of the mark.
Goods and ServicesSales promotion for third parties, business management assistance; [ consulting ] * consultancy * on business management and marketing studies; presentation of goods on [ any kind of ] * all * communication media for retail sale; commercial administration of licenses for the goods and services of others; organization of exhibitions, [ trade fairs or congresses for business ] * trade fairs and conventions for commercial * or advertising purposes, all relating to pharmaceutical, veterinary and biotechnological companies and for pharmaceutical, veterinary and biotechnological products * ; but none of the aforesaid goods relating to neuroscience, including dementia, Alzheimer's disease and Parkinson's disease or to goods in the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease *
NOT AVAILABLE"HEALTHCARE"
Goods and Services[ Surgical apparatus and instruments, medical instruments for treating gynecological disorders, [ ophthalmological ] * ophthalmic * disorders, dermatological disorders, and respiratory and metabolic disorders; Medical test kits for diabetes monitoring for home use; orthopedic devices for diagnostic and therapeutic [ use ] * purposes * ; suture materials ]
Goods and Services[ Chemical, biological and pharmaceutical research services * ; [ all ] * none of * the aforesaid goods relating to the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease * ]

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 24, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status CodeG - NOT AVAILABLE
Class Status DateSunday, June 12, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, February 24, 2014
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeG - NOT AVAILABLE
Class Status DateSunday, June 12, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCHEMO IBERICA, S.A.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBarcelona E-08028
ES

Party NameCHEMO IBERICA, S.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressES

Party NameCHEMO IBERICA, S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressES

Trademark Events


Event DateEvent Description
Monday, February 24, 2014NON-FINAL ACTION WRITTEN
Friday, February 21, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, February 24, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 24, 2014ASSIGNED TO EXAMINER
Tuesday, February 25, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, February 25, 2014REFUSAL PROCESSED BY MPU
Tuesday, February 25, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, February 28, 2014APPLICATION FILING RECEIPT MAILED
Friday, March 14, 2014REFUSAL PROCESSED BY IB
Monday, August 25, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 25, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 25, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 25, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 26, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 29, 2014FINAL REFUSAL WRITTEN
Friday, August 29, 2014NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, August 29, 2014FINAL REFUSAL E-MAILED
Monday, March 2, 2015TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, March 2, 2015EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, March 3, 2015JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, March 3, 2015EX PARTE APPEAL-INSTITUTED
Monday, March 9, 2015ASSIGNED TO LIE
Thursday, March 12, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 12, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 27, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 27, 2015EXAMINERS AMENDMENT E-MAILED
Monday, April 27, 2015EXAMINERS AMENDMENT -WRITTEN
Monday, April 27, 2015EXAMINER'S AMENDMENT ENTERED
Monday, April 27, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 27, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 13, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 13, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 13, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, June 1, 2015NOTIFICATION PROCESSED BY IB
Tuesday, June 2, 2015PUBLISHED FOR OPPOSITION
Tuesday, June 2, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, July 22, 2015NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, July 22, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, August 7, 2015NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, August 18, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, August 19, 2015EXPARTE APPEAL TERMINATED
Wednesday, November 18, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, December 18, 2015LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, February 2, 2016FINAL DISPOSITION PROCESSED
Tuesday, February 2, 2016FINAL DISPOSITION NOTICE SENT TO IB
Saturday, February 20, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, July 1, 2016CORRECTION UNDER SECTION 7 - PROCESSED
Wednesday, July 6, 2016LIMITATION FROM THE IB EXAMINED AND ENTERED
Wednesday, March 1, 2017PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Tuesday, May 2, 2017INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Thursday, September 21, 2017LIMITATION OF GOODS RECEIVED FROM IB
Friday, September 22, 2017CORRECTION TRANSACTION RECEIVED FROM IB
Friday, October 6, 2017LIMITATION OF GOODS RECEIVED FROM IB
Saturday, October 14, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, October 14, 2017CORRECTION UNDER SECTION 7 - PROCESSED
Monday, October 16, 2017CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Tuesday, November 28, 2017LIMITATION FROM THE IB EXAMINED AND ENTERED
Tuesday, March 13, 2018LIMITATION FROM THE IB EXAMINED AND ENTERED
Sunday, June 12, 2022NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Monday, March 12, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, March 12, 2018CORRECTION UNDER SECTION 7 - PROCESSED
Monday, November 12, 2018PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, November 29, 2018INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Tuesday, August 18, 2020COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Monday, August 16, 2021TEAS SECTION 71 RECEIVED
Monday, June 6, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, June 12, 2022REGISTERED - PARTIAL SEC 71 ACCEPTED
Sunday, August 18, 2024COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Wednesday, July 23, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 18, 2025TEAS SECTION 71 & 15 RECEIVED
Wednesday, July 23, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, February 12, 2023PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Tuesday, April 4, 2023INVALIDATION PROCESSED
Tuesday, April 4, 2023PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, May 16, 2023PARTIAL INVALIDATION PROCESSED BY THE IB
Friday, July 14, 2023INTERNATIONAL REGISTRATION RENEWED
Wednesday, July 23, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED